LSV Asset Management’s Amphastar Pharmaceuticals AMPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $992K | Hold |
43,200
| – | – | ﹤0.01% | 608 |
|
|
2025
Q1 | $1.25M | Buy |
43,200
+6,800
| +19% | +$197K | ﹤0.01% | 604 |
|
|
2024
Q4 | $1.35M | Sell |
36,400
-44,000
| -55% | -$1.63M | ﹤0.01% | 586 |
|
|
2024
Q3 | $3.9M | Hold |
80,400
| – | – | 0.01% | 526 |
|
|
2024
Q2 | $3.22M | Sell |
80,400
-144,368
| -64% | -$5.77M | 0.01% | 566 |
|
|
2024
Q1 | $9.87M | Sell |
224,768
-92,832
| -29% | -$4.08M | 0.02% | 439 |
|
|
2023
Q4 | $19.6M | Buy |
317,600
+105,232
| +50% | +$6.51M | 0.04% | 345 |
|
|
2023
Q3 | $9.77M | Hold |
212,368
| – | – | 0.02% | 425 |
|
|
2023
Q2 | $12.2M | Buy |
212,368
+179,168
| +540% | +$10.3M | 0.03% | 399 |
|
|
2023
Q1 | $1.25M | Buy |
33,200
+22,500
| +210% | +$844K | ﹤0.01% | 650 |
|
|
2022
Q4 | $300K | Hold |
10,700
| – | – | ﹤0.01% | 761 |
|
|
2022
Q3 | $301K | Sell |
10,700
-116,353
| -92% | -$3.27M | ﹤0.01% | 760 |
|
|
2022
Q2 | $4.42M | Sell |
127,053
-12,700
| -9% | -$442K | 0.01% | 524 |
|
|
2022
Q1 | $5.02M | Buy |
139,753
+54,907
| +65% | +$1.97M | 0.01% | 526 |
|
|
2021
Q4 | $1.98M | Buy |
84,846
+35,546
| +72% | +$828K | ﹤0.01% | 647 |
|
|
2021
Q3 | $937K | Buy |
49,300
+18,900
| +62% | +$359K | ﹤0.01% | 719 |
|
|
2021
Q2 | $612K | Buy |
+30,400
| New | +$612K | ﹤0.01% | 764 |
|